| scholarly article | Q13442814 |
| P2093 | author name string | Jacek Lubkowski | |
| Wuyuan Lu | |||
| Zhibin Wu | |||
| David M Hoover | |||
| Kenneth Tucker | |||
| P2860 | cites work | Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic | Q24290539 |
| Defensins. Natural peptide antibiotics of human neutrophils | Q24563852 | ||
| Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3 | Q24678725 | ||
| The structure of human beta-defensin-2 shows evidence of higher order oligomerization | Q27625482 | ||
| The solution structures of the human beta-defensins lead to a better understanding of the potent bactericidal activity of HBD3 against Staphylococcus aureus | Q27636772 | ||
| Crystal structure of defensin HNP-3, an amphiphilic dimer: mechanisms of membrane permeabilization | Q27658909 | ||
| Defensins and host defense | Q28138879 | ||
| Epithelial defensins impair adenoviral infection: implication for adenovirus-mediated gene therapy | Q28142767 | ||
| Discovery of new human beta-defensins using a genomics-based approach | Q28202377 | ||
| Identification of a novel, multifunctional beta-defensin (human beta-defensin 3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction | Q28204611 | ||
| Human beta-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity | Q28210164 | ||
| A peptide antibiotic from human skin | Q28242199 | ||
| Structure, function, and membrane integration of defensins | Q28270856 | ||
| hBD-1: a novel beta-defensin from human plasma | Q28294850 | ||
| Cryptdin-3 induces novel apical conductance(s) in Cl- secretory, including cystic fibrosis, epithelia | Q32030771 | ||
| Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides | Q33855582 | ||
| A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated alpha-defensins | Q33876954 | ||
| Penetration of the insect defensin A into phospholipid monolayers and formation of defensin A-lipid complexes | Q33907785 | ||
| Current status of defensins and their role in innate and adaptive immunity | Q34108985 | ||
| Antibacterial activities and conformations of bovine beta-defensin BNBD-12 and analogs:structural and disulfide bridge requirements for activity | Q34113388 | ||
| Susceptibility of nontypeable Haemophilus influenzae to human beta-defensins is influenced by lipooligosaccharide acylation | Q34130303 | ||
| Participation of mammalian defensins and cathelicidins in anti-microbial immunity: receptors and activities of human defensins and cathelicidin (LL-37). | Q34254888 | ||
| Broad-spectrum antimicrobial activity of human intestinal defensin 5. | Q35549706 | ||
| Platelet microbicidal proteins and neutrophil defensin disrupt the Staphylococcus aureus cytoplasmic membrane by distinct mechanisms of action | Q37377013 | ||
| Antimicrobial defensin peptides form voltage-dependent ion-permeable channels in planar lipid bilayer membranes | Q37662088 | ||
| Critical role of lipid composition in membrane permeabilization by rabbit neutrophil defensins | Q38556126 | ||
| Treponema denticola is resistant to human beta-defensins | Q39655539 | ||
| Defensins promote fusion and lysis of negatively charged membranes | Q42843138 | ||
| Interactions between human defensins and lipid bilayers: evidence for formation of multimeric pores | Q42844356 | ||
| DNA as the intracellular secondary target for antibacterial action of human neutrophil peptide-I against Mycobacterium tuberculosis H37Ra | Q43619139 | ||
| Interactions of monomeric rabbit neutrophil defensins with bilayers: comparison with dimeric human defensin HNP-2. | Q46241707 | ||
| Neutrophil defensins: purification, characterization, and antimicrobial testing | Q46771245 | ||
| Engineered salt-insensitive alpha-defensins with end-to-end circularized structures | Q50122491 | ||
| Insect defensin, an inducible antibacterial peptide, forms voltage-dependent channels in Micrococcus luteus. | Q52538293 | ||
| Combinatorial libraries: a tool to design antimicrobial and antifungal peptide analogues having lytic specificities for structure-activity relationship studies. | Q52540321 | ||
| Specific binding sites for an antifungal plant defensin from Dahlia (Dahlia merckii) on fungal cells are required for antifungal activity. | Q54064016 | ||
| In situ neutralization in Boc-chemistry solid phase peptide synthesis. Rapid, high yield assembly of difficult sequences | Q67982257 | ||
| Human neutrophil peptide defensins induce single strand DNA breaks in target cells | Q68004144 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2804-2809 | |
| P577 | publication date | 2003-09-01 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Antimicrobial characterization of human beta-defensin 3 derivatives | |
| P478 | volume | 47 |
| Q47693586 | A 15-amino acid C-terminal peptide of beta-defensin-3 inhibits bone resorption by inhibiting the osteoclast differentiation and disrupting podosome belt formation. |
| Q50279399 | A novel antifungal peptide from foxtail millet seeds |
| Q30882053 | A theoretical approach to spot active regions in antimicrobial proteins. |
| Q31083153 | Alpha-defensins in enteric innate immunity: functional Paneth cell alpha-defensins in mouse colonic lumen |
| Q41033958 | An ancestral host defence peptide within human β-defensin 3 recapitulates the antibacterial and antiviral activity of the full-length molecule |
| Q46819070 | Analysis and separation of residues important for the chemoattractant and antimicrobial activities of beta-defensin 3. |
| Q34782648 | Anti-bacterial activity of recombinant human β-defensin-3 secreted in the milk of transgenic goats produced by somatic cell nuclear transfer |
| Q34463066 | Antibacterial activity of human neutrophil defensin HNP-1 analogs without cysteines |
| Q33794000 | Antibacterial and detoxifying activity of NZ17074 analogues with multi-layers of selective antimicrobial actions against Escherichia coli and Salmonella enteritidis. |
| Q37880638 | Antibiotic activities of host defense peptides: more to it than lipid bilayer perturbation. |
| Q30848083 | Antifungal activities of human beta-defensins HBD-1 to HBD-3 and their C-terminal analogs Phd1 to Phd3. |
| Q36023412 | Antifungal effects of synthetic human β-defensin 3-C15 peptide. |
| Q38081821 | Antifungal proteins: More than antimicrobials? |
| Q42244810 | Antimicrobial activities of chemokines: not just a side-effect? |
| Q53334583 | Antimicrobial activity of human α-defensin 6 analogs: insights into the physico-chemical reasons behind weak bactericidal activity of HD6 in vitro. |
| Q42700440 | Antimicrobial and Antibiofilm Effects of Human Amniotic/Chorionic Membrane Extract on Streptococcus pneumoniae |
| Q41348615 | Antimicrobial characterization of site-directed mutagenesis of porcine beta defensin 2. |
| Q37034707 | Antimicrobial peptides in human skin disease. |
| Q37213664 | Antimicrobial peptides, skin infections, and atopic dermatitis |
| Q55263222 | Beta-defensin derived cationic antimicrobial peptides with potent killing activity against gram negative and gram positive bacteria. |
| Q36741765 | Candida glabrata: an emerging oral opportunistic pathogen |
| Q33927464 | Candidacidal activity of synthetic peptides based on the antimicrobial domain of the neutrophil-derived protein, CAP37 |
| Q89965661 | Cervical Gene Delivery of the Antimicrobial Peptide, Human β-Defensin (HBD)-3, in a Mouse Model of Ascending Infection-Related Preterm Birth |
| Q39203205 | Chimeric beta-defensin analogs, including the novel 3NI analog, display salt-resistant antimicrobial activity and lack toxicity in human epithelial cell lines |
| Q34660888 | Combining flagellin and human β-defensin-3 to combat bacterial infections |
| Q38201011 | Defensins: antifungal lessons from eukaryotes |
| Q47979721 | Deleting the first disulphide bond in an arenicin derivative enhances its expression in Pichia pastoris |
| Q36225275 | Design of antimicrobial peptides conjugated biodegradable citric acid derived hydrogels for wound healing |
| Q57046321 | Did cis- and trans-defensins derive from a common ancestor? |
| Q30397736 | Different dynamics and pathway of disulfide bonds reduction of two human defensins, a molecular dynamics simulation study |
| Q35006475 | Effect of selectively introducing arginine and D-amino acids on the antimicrobial activity and salt sensitivity in analogs of human beta-defensins |
| Q54416370 | Effects of cations and pH on antimicrobial activity of thanatin and s-thanatin against Escherichia coli ATCC25922 and B. subtilis ATCC 21332. |
| Q53281868 | Engineering of a linear inactive analog of human β-defensin 4 to generate peptides with potent antimicrobial activity. |
| Q91657465 | Escherichia coli Lipopolysaccharide Modulates Biological Activities of Human-β-Defensin Analogues but Not Non-Ribosomally Synthesized Peptides |
| Q48119996 | Evidence of an abnormal epithelial barrier in active, untreated and corticosteroid-treated eosinophilic esophagitis |
| Q52647380 | Expression of recombinant HBD3 protein that reduces Mycobacterial infection capacity. |
| Q51819406 | Expression profile of human beta-defensin 3 in oral squamous cell carcinoma. |
| Q41910405 | Factors affecting antimicrobial activity of MUC7 12-mer, a human salivary mucin-derived peptide. |
| Q27643563 | Fowlicidin-3 is an alpha-helical cationic host defense peptide with potent antibacterial and lipopolysaccharide-neutralizing activities |
| Q33327073 | Highly active and selective endopeptidases with programmed substrate specificities |
| Q37053332 | Human antimicrobial proteins effectors of innate immunity |
| Q34737252 | Human beta-defensin 2 and beta-defensin 3 chimeric peptides reveal the structural basis of the pathogen specificity of their parent molecules |
| Q35635804 | Human beta-defensins kill Candida albicans in an energy-dependent and salt-sensitive manner without causing membrane disruption |
| Q40433088 | Human beta-defensins: differential activity against candidal species and regulation by Candida albicans |
| Q38015881 | Human genetic susceptibility to Candida infections. |
| Q35580348 | Human β-defensin 4 with non-native disulfide bridges exhibit antimicrobial activity |
| Q36010308 | Identification of a cell-penetrating peptide domain from human beta-defensin 3 and characterization of its anti-inflammatory activity |
| Q46976807 | In situ production of human β defensin-3 in lager yeasts provides bactericidal activity against beer-spoiling bacteria under fermentation conditions. |
| Q54365857 | In vitro antibacterial and hemolytic activities of crotamine, a small basic myotoxin from rattlesnake Crotalus durissus. |
| Q35744702 | In vivo expression of antimicrobial peptides in atopic dermatitis |
| Q55287016 | Induction of Avian β-Defensin 2 Is Possibly Mediated by the p38 MAPK Signal Pathway in Chicken Embryo Fibroblasts After Newcastle Disease Virus Infection. |
| Q27676478 | Initial Insights into Structure-Activity Relationships of Avian Defensins |
| Q35784013 | Mechanisms of decreased susceptibility to beta-defensins by Treponema denticola |
| Q37393664 | Medical mycology and fungal immunology: new research perspectives addressing a major world health challenge |
| Q40478628 | Membrane damage and repair in primary monocytes exposed to human β-defensin-3 |
| Q35027911 | Membrane disruptive antimicrobial activities of human β-defensin-3 analogs |
| Q50072115 | Modification of chicken avian beta-defensin-8 at positively selected amino acid sites enhances specific antimicrobial activity. |
| Q58746619 | Modification of the surface of titanium with multifunctional chimeric peptides to prevent biofilm formation via inhibition of initial colonizers |
| Q38824103 | Modulation of host defense peptide-mediated human mast cell activation by LPS. |
| Q33769013 | Molecular cloning and characterization of three beta-defensins from canine testes |
| Q42606648 | Molecular diversity of the antimicrobial domain of beta-defensin 3 and homologous peptides |
| Q35565673 | N-terminus three residues deletion mutant of human beta-defensin 3 with remarkably enhanced salt-resistance |
| Q39709081 | Native thrombocidin-1 and unfolded thrombocidin-1 exert antimicrobial activity via distinct structural elements |
| Q35950558 | Nonviral human beta defensin-3 expression in a bioengineered human skin tissue: a therapeutic alternative for infected wounds |
| Q36288808 | Novel synthetic analogues of avian β-defensin-12: the role of charge, hydrophobicity, and disulfide bridges in biological functions |
| Q33876601 | Novel synthetic, salt-resistant analogs of human beta-defensins 1 and 3 endowed with enhanced antimicrobial activity |
| Q58585193 | Partial peptides from rice defensin OsAFP1 exhibited antifungal activity against the rice blast pathogen |
| Q33533544 | Peptide fragments of a beta-defensin derivative with potent bactericidal activity |
| Q59098659 | Peptide gets in shape for self-defence |
| Q33700825 | Perspectives for clinical use of engineered human host defense antimicrobial peptides |
| Q63408299 | Proteolytic Degradation of reduced Human Beta Defensin 1 generates a Novel Antibiotic Octapeptide |
| Q35998473 | Psoriatic scales: a promising source for the isolation of human skin-derived antimicrobial proteins |
| Q36670932 | Reduction Impairs the Antibacterial Activity but Benefits the LPS Neutralization Ability of Human Enteric Defensin 5 |
| Q99556607 | Reverse vaccinology assisted designing of multiepitope-based subunit vaccine against SARS-CoV-2 |
| Q36799596 | Role of host-defence peptides in eye diseases |
| Q38802524 | Sequential and Structural Aspects of Antifungal Peptides from Animals, Bacteria and Fungi Based on Bioinformatics Tools |
| Q36683469 | Short, Synthetic Cationic Peptides Have Antibacterial Activity against Mycobacterium smegmatis by Forming Pores in Membrane and Synergizing with Antibiotics |
| Q52656373 | Simulating the antimicrobial mechanism of human β-defensin-3 with coarse-grained molecular dynamics. |
| Q35702275 | Snake Cathelicidin NA-CATH and Smaller Helical Antimicrobial Peptides Are Effective against Burkholderia thailandensis |
| Q27689684 | Structure and antimicrobial activity of platypus 'intermediate' defensin-like peptide |
| Q45022873 | Structure-activity relationships in defensin dimers: a novel link between beta-defensin tertiary structure and antimicrobial activity |
| Q36128939 | Structure-function analysis of Avian β-defensin-6 and β-defensin-12: role of charge and disulfide bridges |
| Q54452869 | Studies of the biological properties of human beta-defensin 1. |
| Q92156594 | Synthetic Human β Defensin-3-C15 Peptide in Endodontics: Potential Therapeutic Agent in Streptococcus gordonii Lipoprotein-Stimulated Human Dental Pulp-Derived Cells |
| Q39413308 | Targeting a cell wall biosynthesis hot spot |
| Q95840995 | The Antimicrobial Peptide Human Beta-Defensin 2 Inhibits Biofilm Production of Pseudomonas aeruginosa Without Compromising Metabolic Activity |
| Q27676502 | The Cyclic Cystine Ladder in -Defensins Is Important for Structure and Stability, but Not Antibacterial Activity |
| Q33836880 | The antimicrobial activity of CCL28 is dependent on C-terminal positively-charged amino acids |
| Q46702870 | The plant defensin, NaD1, enters the cytoplasm of Fusarium oxysporum hyphae |
| Q37017370 | The role of antimicrobial peptides at the ocular surface |
| Q50092750 | The synthetic form of a novel chicken beta-defensin identified in silico is predominantly active against intestinal pathogens |
| Q41993537 | The synthetic human beta-defensin-3 C15 peptide exhibits antimicrobial activity against Streptococcus mutans, both alone and in combination with dental disinfectants |
| Q43470518 | The synthetic peptides bovine enteric β-defensin (EBD), bovine neutrophil β-defensin (BNBD) 9 and BNBD 3 are chemotactic for immature bovine dendritic cells |
| Q35765997 | Toll-like receptor 1 polymorphisms increase susceptibility to candidemia. |
| Q28487155 | Toll-like receptor signaling activation by Entamoeba histolytica induces beta defensin 2 in human colonic epithelial cells: its possible role as an element of the innate immune response |
| Q47557198 | Towards the Application of Human Defensins as Antivirals |
| Q35173769 | Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals? |
Search more.